X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

    Oracle Wins the Asia Pacific Biopharma Excellence Awards

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

    Advanced Instruments All Set To Merge With Nova Biomedical

    Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

    Oracle Wins the Asia Pacific Biopharma Excellence Awards

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

Mettler-Toledo Launches X2 Series of X-ray Solutions to Bring Enhanced Product Safety to a Wider Audience

Content Team by Content Team
15th May 2023
in Drug Development, News
Mettler-Toledo Launches X2 Series of X-ray Solutions to Bring Enhanced Product Safety to a Wider Audience

Mettler-Toledo Product Inspection has launched the X2 Series of high-performing x-ray systems to help enhance product safety at an incredible price point for all pharma manufacturers. With two x-ray systems currently in the X2 Series, x-ray inspection is now accessible for all budgets, offering manufacturers software that is designed to last longer and perform better.

The creative design of the X2 Series helps enhance brand protection and product safety while also increasing product quality. Helping manufacturers to meet pharma safety compliance requirements, while also offering enhanced productivity, the X2 Series, delivers outstanding reliability with a smart industrial design.

The X2 Series helps prevent product recalls with outstanding contamination detection capabilities that go beyond detecting just metal. The x-ray inspection technology detects a wide range of contaminants, including glass, metal, mineral stone, dense plastic and rubber compounds whilst simultaneously completing a number of quality control and integrity checks. The X2 Series offers significant benefits both in-line and at end-of-line inspection by using innovative technology all designed for optimum performance and output.

Intelligent Software

State-of-the-art ContamPlus™ software is an innovative inspection process which scans products for every kind of contaminant and not just the ones optimised during the initial automatic product set-up. The automatic set-up detects the most hard-to-find foreign bodies and rejects only the contaminated products, reducing production waste and protecting productivity. This is especially crucial for pharma manufacturers, where product integrity and completeness is key, as missing information or products can lead to costly recalls, and sometimes, dangerous results.

ContamPlus™ facilitates new product set-up with just a few passes and without the need for complicated programming or extensive training. Product details are stored and easily recalled for smooth and fast product changeovers to help minimise downtime and boost productivity.

Smart Industrial Design

Every detail of the X2 Series technology is optimised to offer superior performance. At the heart of the design is a new product inspection chamber and a revolutionary modular mechanical design which allows full frontal access to all the most common operations. It offers a range of new features to improve operations such as product handling, cleaning and service routines. The X2 Series’ range of standard length and height configurations is complemented by bespoke designs to allow total customisation to meet exact customer needs.

Pharma manufacturers can significantly reduce cleaning output and maintenance routines as well as the need for complex operator training with the X2 Series’ front-opening hygienic design. Designed for efficient cleaning, the solution makes it easy for operators to perform regular maintenance routines. The conveyor belt can be removed swiftly and without tools by releasing the tension with the handle situated on the infeed roller. The lead-free, low friction curtains also allow smooth product transition through the machine, with the presence of curtains constantly monitored to help keep the operator safe.

The new multi-fit reject device option is suitable for most common applications, with other options available on request. With reliable rejection and due diligence of products, the design enhances brand protection and helps ensure all end products are the optimum quality when they reach the customer.

Compliance

With the X2 Series, manufacturers are easily able to comply with industry standards and regulations such as CFR21 Part II by providing full traceability through an audit trail and recorded image database. A review of contaminated products is also easily managed with the new stainless steel reject bin, which safely collects substandard products to avoid production line contamination, allowing manufacturers to review the product and its contamination.

Improved Total Cost of Ownership

The X2 Series combines superior industrial design with simplified cleaning routines. Its intuitive user interface and a highly reliable set of state-of-the-art subsystems such as the generator and detectors, helps to improve Overall Equipment Effectiveness and lower Total Cost of Ownership. With extensive service solutions and a five-year generator warranty, manufacturers can feel confident in keeping their systems running at optimal capacity for longer periods of time.

Manufactured in Europe, the X2 Series consists of two models – the X12 and X32, both are available in multiple line configurations 800, 1300, 1800 and 2000 mm line lengths:

X12 High Performance X-ray System: This high performing single-lane x-ray inspection system comes as standard and is available at an incredible price point, featuring the HiGain detector, which generates sharper images to deliver outstanding contaminant detection.

X32 Advanced X-ray Solution: Offering enhanced sensitivity and product integrity performance, this x-ray inspection solution features the HiGain+ detector and is available in standard and custom configurations, with single or multi-lane capabilities.

“We are hoping to change the mindsets of all pharma manufacturers with our new X2 Series that they can now install a high-end x-ray inspection solution at an affordable price point for all,” said Mike Pipe, Head of Global Sales & Product Management, Mettler-Toledo Safeline X-ray. “By utilising global service hubs and reducing spare parts, we are confident we have created an innovative solution that is easy to install, environmentally more sustainable and suitable for any budget. With a current 14-day lead time, we can work with manufacturers to install one of our new X2 Series x-ray systems quickly and efficiently, helping them to increase product quality and protect their brand reputation”.

 

Previous Post

European Medicines Agency Ends COVID-19 Prioritization Plan

Next Post

Key Areas For AI/ML Drug Development - FDA Discussion Paper

Related Posts

Clinical Development
Articles

AI Revolutionizing Drug Discovery and Clinical Development

19th April 2025
DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Drug-Development
Articles

China’s Super Me-Too Drug Development: A New Pharma Frontier

18th April 2025
Omics Based Clinical Trials
Asia

Asia Pacific Omics-Based Clinical Trials Market Growth

16th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Insights

AstraZeneca Eyes Acquisition To Develop Cell Therapies

24th March 2025
Next Post

Key Areas For AI/ML Drug Development - FDA Discussion Paper

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In